Familial hypercholesterolaemia trials in Germany
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Where
- Freiburg im Breisgau, Hanover, Magdeburg
- Age
- 6 years to 17 years
- People
- 153 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07058077 · EU 2024-519068-42-00 - Phase 3Taking peopleStudy to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemia
- Where
- Frankfurt Am Main
- Age
- Up to 17 years
- People
- 8 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-514595-41-00 · EU 2024-514595-41-00 - Phase 3Not yet taking people in GermanyA Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
- Where
- Berlin, Hamburg, Mainz, Mannheim
- Age
- 18 years and over
- People
- 103 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07474649 - Phase 3Taking peopleLong-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Where
- Frankfurt am Main, Freiburg im Breisgau
- Age
- 2 years to 100 years
- People
- 195 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05682378 - Phase 3Taking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Frankfurt am Main
- Age
- 2 years to 11 years
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - Phase 4Taking peopleEarly TRIPLE versus dual LIPID lowering treatment in peOple with atherosclerotic cardiovascular disease and hypercholesterolemia Undergoing elecTive revascularisation
- Where
- Dresden, Mainz, Regensburg
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Medical University Of Graz
See details and how to join2026-525917-29-00 · EU 2026-525917-29-00 - Phase 3Taking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Frankfurt am Main, Freiburg im Breisgau, Hanover
- Age
- 6 years to 11 years
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019